CD28 and cancer: This prompted us to analyze expression of costimulatory molecules on cancer cell lines and we observed that JY-LCL cells expressed high levels of the CD28 ligands CD80 and CD86, whereas these molecules were not detected on 518A2, K562 and U266 cells, which only elicited weak responses (Supplementary Figure 1A).